Global Breast Biopsy Market Growth (Status and Outlook) 2023-2029

Global Breast Biopsy Market Growth (Status and Outlook) 2023-2029

A breast biopsy is the procedure of locating a diseased tissue in the breast and collecting the specimen sample of the area for further examination and diagnosis. Breast biopsies are performed by using minimally invasive biopsy systems, owing to minimal disfigurement and pain. Non-invasive biopsy techniques provide preventive measures that assist physicians in diagnosing and treating high-risk breast cancer. This information prevents the application of chemotherapy in breast cancer, reducing the complexities of chemo-radiations. Vacuum assisted breast biopsy devices (VAB), core needle biopsies and fine needle aspiration biopsy are commonly used to perform biopsy procedures.

LPI (LP Information)' newest research report, the “Breast Biopsy Industry Forecast” looks at past sales and reviews total world Breast Biopsy sales in 2022, providing a comprehensive analysis by region and market sector of projected Breast Biopsy sales for 2023 through 2029. With Breast Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breast Biopsy industry.

This Insight Report provides a comprehensive analysis of the global Breast Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Breast Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Breast Biopsy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breast Biopsy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breast Biopsy.

The global Breast Biopsy market size is projected to grow from US$ 517.2 million in 2022 to US$ 919.6 million in 2029; it is expected to grow at a CAGR of 8.6% from 2023 to 2029.

Approximately 12% women in the U.S. are likely to develop breast cancer during their lifetime. Factors contributing to rise in breast cancer cases is over consumption of alcoholic drinks, lack of physical exercise, improper diet and eating habits, high level of hormonal imbalance & exposure of skin to intense sunlight. However, limited awareness among female population and substandard healthcare facilities especially in developing regions are the factor restraining the growth of breast biopsy market.

This report presents a comprehensive overview, market shares, and growth opportunities of Breast Biopsy market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Needle-Based Biopsy Systems
Breast Biopsy Needles
Biopsy Imaging Guidance Systems
Others

Segmentation by application
Hospitals
ASC
Research Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
C.R. Bard
Hologic
Leica Biosystems
Argon Medical Devices
Aurora Imaging
Carestream Health
Cook Medical
Fischer Medical Technologies
Intact Medical
Internazionale Medico Scientifica
Metaltronica
Sectra
Terason
ZAMAR CARE

Please note: The report will take approximately 2 business days to prepare and deliver.